Dizziness Clinical Trial
Official title:
Comparison of Clinical and Game-based Rehabilitation for Balance Impairments and Gaze Dysfunction in Clients With Vestibular Disorders
Study Description and Purpose:
The vestibular sense organs of the inner ear consist of the semi-circular canals and otolith
end organs. These organs contain specialized gravito-inertial sensors that sense angular and
linear head acceleration. The input from these sensors is required to stabilize gaze
position during head motion, and provide an absolute frame of reference with respect to
gravity, thus providing a vertical spatial reference for body orientation and balance.
Disease or damage of the vestibular sense organs causes a range of distressing symptoms and
functional problems for people that could include loss of balance, gaze instability,
disorientation and dizziness. A novel computer based rehabilitation system with therapeutic
gaming application has been developed. This method allows different gaze and head movement
exercises to be coupled to a wide range of inexpensive, commercial computer games. It can be
used in standing and thus graded balance demands using a sponge pad can be incorporated into
the program.
Study Objective:
1. Test the therapeutic effectiveness of the TRP delivered in the home compared to usual
care delivered in an out-patient physical therapy clinic on measures of balance
(standing and walking) , gaze control, dizziness, and health related quality of life in
individuals with peripheral vestibular disorders.
2. Compare trajectory of change in electronic gaze performance measures obtained during
each therapy session of each participant assigned to the home Telerehabilitation.
Hypothesis:
Investigators believe the Telerehabilitation platform to be a cost-effective delivery of
rehabilitation. Additionally motivation to perform tedious home programs can be improved
with engaging, fun and interactive computer gaming as part of the rehabilitation process. It
is hypothesized the home game-based Telerehabilitation program will result in greater
improvements in dynamic balance control, gaze control, and dizziness, in individuals with
peripheral vestibular disorders as compared to a typical out-patient physical therapy
regimen.
Protocol
Design & Methodology:
This study will adopt a randomized clinical trial design. Recruitment and screening
(including diagnostics) will be coordinated by co-applicant, Dr. Jordon Hochman, department
of Otolaryngology, Karen Reimer, and Andrea Giacobbo,; Physical Therapists.
Inclusion criteria:
Consist of (a) age 18 to 65 , (b) diagnosed with unilateral peripheral vestibular hypo
function based on a detailed neuro-otological and neuro-orthoptic analysis to include
binocular electro-oculography with caloric testing, and (c) have a home computer running
Windows or Mac OS.
Exclusion criteria:
Consist of those with CNS disorders for example CVA, Multiple Sclerosis, epilepsy,
migraines, concussion recent fractures of the lower extremities or vertebra, advanced
hip/knee OA , and cardiac disease. Participants will be randomly assigned to either the
Control group (active comparator) or Experimental group (therapeutic gaming). Participants
will be blinded to the treatment. The treating therapist will know who is receiving the home
or out-patient clinical program.
Control group will receive; (a) Herdman gaze stabilization exercises, (b) optokinetic
exercises, and (c) balance exercises using sponge pads. These exercises are presently a
standard of vestibular care. Participants will attend an out-patient physical therapy clinic
once a week for 8-10 weeks. The program also includes a 20 minute home exercise program
prescribed four times per week.
Experimental group: Will receive the game-based rehabilitation program delivered at home.
The program for gaze will include provision of the motion mouse (Gyration). This approach
provides a highly flexible treatment tool applied to train gaze control, and allows
incorporation of graded balance demands. The use of this HID compliant computer input device
allows many different therapeutic exercises to be coupled to a wide range of inexpensive
commercial computer games. Though initially designed for clinical use, with the easy to use
and inexpensive motion sense mouse and computer games this intervention approach can be
extended to home settings. Many therapeutic exercises and activities (singly or in
combination) can be used to practice a variety of gaze and balance skills, and, importantly,
while playing fun computer games.
Participants will attend three clinical sessions during which time the home therapy programs
will be established and training in the use of the computer, motion mouse and games will be
provided. Based on clinical experience and pilot data, three sessions is sufficient before
initiating the home program.16 The treating physiotherapist will attend the participant's
home to ensure proper set-up and operation of the TRP equipment and computer applications.
Participants will be asked to perform their respective home programs four times per week for
20 minutes per session. They will receive a phone call at one week to assess their ability
to manage their home program. Thereafter participants will attend for clinical follow-up
once per month.
Recording and Data Analysis The following information will be collected at baseline prior to
start of the interventions; age, gender, work history, occupation and (history of
disease/injury process, and current medications. Assessor will be blinded to participant
assignments.
Primary Outcome Measures:
1. Clinical Test of Sensory Interaction in Balance (CTSIB); performance-based measure of
balance under altered sensory conditions).
2. Dizziness Handicap Inventory (DHI), is a self-rating questionnaire based on 25
questions used to quantify a client's perception of his or her dizziness and its impact
on their life.
Secondary outcome measures:
1. Computerized Visual tracking test (CVT), involves tracking a bright visual target
moving horizontally left and right on a computer display in a sinusoidal fashion for
several cycles, and at predetermined speeds. The application records (80 Hz)
coordinates of both reference and head cursors. Coefficient of determination (COD) will
be computed based on total and average residual difference between trajectories of the
reference and head cursor motions. A value approaching one equates to excellent gaze
performance. This test will be performed in standing and while walking on a treadmill
at 0.9 m/s.
2. Participants in the experimental group will be given the visual tracking game
application for home use. The game software automatically logs reference and head
cursor coordinates (gaze performance) during the visual tracking task and saves the
data to a coded and time stamped computer file (anatomized). Participants will be asked
to play the tracking task (in standing at the beginning of every training session. This
will involve three short tests of 45 seconds at three tracking speeds. The application
automatically saves the logged data file, and the clients can either e-mail the files
to the investigator, or save on a flash drive provided and return at a follow-up visit.
3. Spatiotemporal gait variables and walking stability measures. This is included to
examine whether the exercise program transfers to walking. A treadmill instrumented
with a pressure mat (Vista Medical, CA) will be used to record vertical foot forces for
each step during walking trials of 1 minute at 0.9 m/s, and thus data for 40
consecutive steps.
4. Participants will be ask to complete a log of dates and duration of each exercise
session, and submit either a paper version or by e-mail.
Statistical Analysis & Power Assessment: Descriptive statistics, including means, standard
deviations, frequencies, and percentages, will be used to describe the experimental and
control groups on the baseline demographic variables. Differences between the groups on the
outcomes will be tested using t-tests and tests of independence.
To achieve Objective 1, we will test the difference between experimental and control groups
on continuous and normally distributed outcome measures using analysis of covariance, with
the dependent variable being the post-intervention measurement of the outcome, the covariate
being the pre-intervention measurement, and group membership as the between-subjects effect.
Descriptive statistics, including measures of skewness and kurtosis, will be used to assess
departures from the assumptions of a normal distribution of responses. If the distribution
contains extreme observations, a robust ANCOVA statistic will be adopted. To test
differences between experimental and control groups on discrete outcomes, such as counts of
number of times participants feel dizzy during their daily activities, we will use a Poisson
regression model, with the dependent variable being a count of the number of relevant
events, the covariate being the pre-intervention measurement, and group membership as the
between-subjects effect.
To analyze the longitudinal data associated with Objective 2, we will use a mixed-effects
regression model with time as the random effect and group as the fixed effect. This model
will be adopted because it accounts for clustering of repeated measurements within study
participants and uses all available longitudinal data (i.e., it does not result in case-wise
deletion of study participants due to missing observations.
Based on pilot data for the primary outcome (i.e., CTSIB), we conducted a power analysis of
the required sample size to test the difference between the experimental and controls groups
at the post-intervention measurement occasion (i.e., objective 1). The pilot data showed a
standardized effect size of 0.80. Assuming the number of model covariates to be 3, the
proportion of variance explained by these covariates to be 10%, and a two-tailed test of the
null hypothesis of no group difference at p = .05, a sample size of 46 is required. We
expect an attrition rate of 20% over the study observation period for objective 2. Given
this, we propose to recruit a sample of N = 56 individuals to participate, with equal
numbers to be recruited to the treatment and control groups.
;
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04196933 -
Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
|
N/A | |
Completed |
NCT05427097 -
Thermal Energy in the Treatment of Cervicogenic Dizziness
|
N/A | |
Completed |
NCT02299128 -
Effectiveness of Early Physical Therapy Intervention for Patients With Dizziness After a Sports-Related Concussion
|
N/A | |
Completed |
NCT02733549 -
Is The Sudden Onset of Dizziness A Symptom of Acute Liver Dysfunction?
|
N/A | |
Completed |
NCT05812209 -
Stellate Ganglion Block to Treat Long COVID 19 Case Series
|
||
Not yet recruiting |
NCT03973658 -
Dizziness Among First Time Users of Hearing Aids
|
||
Completed |
NCT03182868 -
Vestibular Testing: Consistency and Effects Over Time
|
N/A | |
Completed |
NCT02938221 -
Telemedical Examination of a Three-Component Oculomotor Testing Battery
|
N/A | |
Active, not recruiting |
NCT02655575 -
Assessment and Treatment of Patients With Long-term Dizziness in Primary Care
|
N/A | |
Completed |
NCT02772042 -
Traction Manipulation of Upper Cervical Spine on Cervicogenic Dizziness
|
N/A | |
Completed |
NCT00732797 -
A Trial of Booklet Based Self Management of Dizziness
|
N/A | |
Not yet recruiting |
NCT06010550 -
Validating a Clinical Decision Support Tool for Stratifying Stroke Risk for Dizziness/Vertigo
|
||
Recruiting |
NCT03618199 -
Efficacy of a Transcranial Vibrating System for Minimizing Dizziness During Caloric Testing
|
N/A | |
Completed |
NCT03330262 -
Head-Mounted Vibrotactile Prosthesis for Patients With Chronic Postural Instability
|
N/A | |
Completed |
NCT05157399 -
Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness
|
N/A | |
Completed |
NCT02344446 -
Physical Therapy Intervention for Extended Physical Symptoms After a Sports-related Concussion
|
N/A | |
Withdrawn |
NCT00732108 -
Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated Dizziness
|
N/A | |
Active, not recruiting |
NCT05122663 -
Emergency Department Vestibular Rehabilitation Therapy for Dizziness and Vertigo
|
||
Recruiting |
NCT05634902 -
Implementation of Evidence-Based Practice for Dizziness
|
N/A | |
Completed |
NCT02640599 -
Stationary Bike Study
|
N/A |